Regulatory scientists’ work has important ramifications for public health and should be open to public scrutiny
Abstract The Swedish Medical Products Agency (MPA) objects to the fact that we occasionally refer to one of its senior ex-employees by name. However, names of individual MPA assessors, Food and Drug Administration (FDA) reviewers, and European Medicines Agency rapporteurs and co-rapporteurs are cite...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | Health Research Policy and Systems |
Online Access: | http://link.springer.com/article/10.1186/s12961-018-0371-4 |